Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
69,530,797
-
Share change
-
+1,093,097
-
Total reported value
-
$5,130,106,470
-
Put/Call ratio
-
28%
-
Price per share
-
$73.78
-
Number of holders
-
366
-
Value change
-
+$81,009,114
-
Number of buys
-
179
-
Number of sells
-
147
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2022
As of 31 Mar 2022 GLOBUS MEDICAL INC - Class A Stock (GMED) had 366 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 69,530,797 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Capital Research Global Investors, RTW INVESTMENTS, LP, Champlain Investment Partners, LLC, and AXA S.A..
This table shows 366 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.